Quotes 5-day view Delayed Nasdaq
Estimated financial data (e) (USD)
Net income 2022
Net cash position 2022
P/E ratio 2022
Net income 2023
Net cash position 2023
P/E ratio 2023
EV / Sales 2022
EV / Sales 2023
Nbr of Employees
Aldeyra Therapeutics, Inc. is a biotechnology company, which is engaged in developing immune-modulating therapies to treat ocular and systemic diseases. The Company's lead product candidate, reproxalap, is a treatment in late-stage development for dry eye disease (DED) and allergic conjunctivitis (AC). It has additional product candidates in development for proliferative vitreoretinopathy (PVR), primary...
Ratings of Aldeyra Therapeutics, Inc.
All news about ALDEYRA THERAPEUTICS, INC.
05/18 Aldeyra Therapeutics Announces that Post-Hoc Analysis Using Computer Automated Grading ..
05/18 ALDEYRA THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
05/05 ALDEYRA THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition..
05/05 TRANSCRIPT : Aldeyra Therapeutics, Inc., Q1 2022 Earnings Call, May 05, 2022
05/05 ALDEYRA THERAPEUTICS, INC. : Results of Operations and Financial Condition, Other Events, ..
05/05 Earnings Flash (ALDX) ALDEYRA THERAPEUTICS Posts Q1 Loss $-0.29
05/05 Aldeyra Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 3..
05/05 Aldeyra Therapeutics Reports First-Quarter 2022 Financial Results and Recent Corporate ..
05/04 Aldeyra Therapeutics to Present at MOD Live! 2022 Meeting
04/29 Omega Therapeutics Hires Aldeyra Therapeutics Chief Financial Officer Joshua Reed for S..
04/28 ALDEYRA THERAPEUTICS : Announces Chief Financial Officer Transition - Form 8-K
04/28 ALDEYRA THERAPEUTICS, INC. : Change in Directors or Principal Officers, Financial Statemen..
04/28 Aldeyra Therapeutics Announces Chief Financial Officer Transition
04/28 Aldeyra Therapeutics, Inc. Announces Executive Changes, Effective May 10, 2022
04/28 Aldeyra Therapeutics, Inc. Announces Management Changes, Effective May 10, 2022
News in other languages on ALDEYRA THERAPEUTICS, INC.
Analyst Recommendations on ALDEYRA THERAPEUTICS, INC.
Chart ALDEYRA THERAPEUTICS, INC.
Technical analysis trends ALDEYRA THERAPEUTICS, INC.
Short Term Mid-Term Long Term Trends Bearish Bearish Bearish
Number of Analysts
Last Close Price
Average target price
Spread / Average Target